BANZEL

This brand name is authorized in Canada, United States

Active ingredients

The drug BANZEL contains one active pharmaceutical ingredient (API):

1 Rufinamide UNII WFW942PR79 - RUFINAMIDE

Rufinamide is an anticonvulsant medication. Rufinamide modulates the activity of sodium channels, prolonging their inactive state. Read about Rufinamide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BANZEL Film-coated tablet / Oral suspension	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AF03	Rufinamide	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AF Carboxamide derivatives
Discover more medicines within N03AF03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02369613, 02369621, 02369648
Country: US	FDA, National Drug Code	Identifier(s): 62856-582, 62856-583, 62856-584